Effects of a supervised, outpatient exercise and physiotherapy programme in children with cystic fibrosis

Pediatric Pulmonology
Donald UrquhartMatthew Tallis

Abstract

Previous work suggests benefit from outpatient exercise and physiotherapy in children with cystic fibrosis (CF), namely improved exercise capacity and lung function measures, as well reduced intravenous (IV) antibiotic needs. Our study aim was to investigate the effect of a year-long supervised outpatient exercise and physiotherapy programme in children with CF. Subjects with CF aged ≥10 years who had received ≥4 courses of IV antibiotics in 2009 were enrolled and seen fortnightly for supervised exercise and physiotherapy throughout 2010. In addition, they were expected to exercise three times weekly, and if unwell complete additional physiotherapy sessions extra to usual chest physiotherapy. Assessments of exercise capacity using the Modified Shuttle Test (MST) and quality of life (QOL; CFQ-UK) were recorded at baseline and after 1 year. Regular spirometry was performed before and throughout the study. Data were collected on IV antibiotic days. 12 subjects (6 female) were enrolled with mean (95% CI) age of 13.3 (11.8-14.6) years at study entry. A significant reduction in IV antibiotic days from 60 (56-64) days in 2009 to 50 (44-56) in 2010 (P = 0.02) was noted, along with improved MST distance (m) [735 (603-867) vs. 943 (725-1...Continue Reading

References

Dec 17, 1992·The New England Journal of Medicine·P A NixonC F Doershuk
Mar 1, 1997·Thorax·A J MoorcroftA K Webb
Mar 4, 2000·The Journal of Pediatrics·J Schneiderman-WalkerJ J Reisman
Jan 15, 2003·Pediatric Pulmonology·Hiran C SelvaduraiPeter P Van Asperen
Dec 11, 2003·Chest·Peter H C KlijnCornelis K van der Ent
Jun 24, 2004·Pediatric Pulmonology·Attilio TurchettaAndrew Bush
Oct 7, 2004·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Peter H KlijnCornelis K van der Ent
Jun 30, 2006·The European Respiratory Journal·H HebestreitS Kriemler
Apr 2, 2008·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·K HindS P Conway
Jul 4, 2009·American Journal of Respiratory and Critical Care Medicine·Sanja StanojevicUNKNOWN Asthma UK Spirometry Collaborative Group
Aug 1, 2009·The European Respiratory Journal·H HebestreitS Kriemler
Dec 4, 2009·Health and Quality of Life Outcomes·Anne SchmidtDoris Staab
Oct 4, 2011·Archives of Disease in Childhood·Sally EyersRichard Beasley

❮ Previous
Next ❯

Citations

Feb 21, 2013·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Sean J LedgerPaul Aurora
Sep 11, 2013·Pediatric Pulmonology·Margarita PérezAlejandro Lucia
Mar 15, 2013·Respiratory Medicine·Theodore DassiosGabriel Dimitriou
May 23, 2016·Revue des maladies respiratoires·C Le GalG Reychler
Oct 4, 2016·Respiratory Medicine·Raquel Pinto CarboneraMárcio Vinícius Fagundes Donadio
Jan 15, 2017·The Journal of Pediatrics·Márcio V F DonadioPaulo J C Marostica
Nov 30, 2018·Expert Review of Respiratory Medicine·Narelle S Cox, Anne E Holland
Feb 7, 2019·Voprosy kurortologii, fizioterapii, i lechebnoĭ fizicheskoĭ kultury·A N RazumovN A Mikitchenko
Sep 22, 2015·Current Opinion in Pulmonary Medicine·Helge HebestreitThomas Radtke
Nov 28, 2019·BMC Pulmonary Medicine·S DenfordUNKNOWN Youth Activity Unlimited – A Strategic Research Centre of the UK Cystic Fibrosis Trust
Jan 11, 2021·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·Márcio Vinícius Fagundes DonadioEvanirso Silva Aquino
Feb 23, 2021·Respiratory Physiology & Neurobiology·G KaltsakasI Vogiatzis
Apr 2, 2021·Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace·Evgenia I KalamaraGuergana Petrova
May 1, 2021·Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace·Anna BrivioSimone Gambazza
Oct 22, 2021·Pediatric Pulmonology·Nicola J Rowbotham, Tracey E Daniels

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.